CSTL FY 2024 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$332M+51.1% YoY

Gross Profit

$272M81.9% margin

Operating Income

$9M2.6% margin

Net Income

$18M5.5% margin

EPS (Diluted)

$0.62

Cash Flow

Operating Cash Flow

$65M

Free Cash Flow

$37M

Stock-Based Comp.

$50M

Balance Sheet

Total Assets

$531M

Total Liabilities

$75M

Stockholders' Equity

$456M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$332M	$220M	+51.1%
Gross Profit	$272M	$175M	+55.5%
Operating Income	$9M	-$68M	+112.8%
Net Income	$18M	-$57M	+131.7%